UNSPSC 85612541: Revision of intraluminal device in hepatobiliary duct, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of intraluminal device in hepatobiliary duct, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FWB3DZ

UNSPSC 85612541 Revision of intraluminal device in hepatobiliary duct, percutaneous approach is a Commodity code with no relevant recent state and local procurement activity. The recent opportunities tagged to this code span independent medical evaluations for public safety pension disability determinations, surgical and medical procedure carve-out benefits for municipal employees, occupational medical surveillance for state transportation workers, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve hepatobiliary duct procedures or intraluminal device placement and revision. The mismatch between the code's nominal scope and the actual work being solicited indicates either a cataloging error in the underlying procurement system or a fundamental misalignment between the UNSPSC taxonomy and how these jurisdictions are tagging their healthcare services purchases.

State and local buyers appear to be using this code as a catch-all for medical services procurement rather than adhering to the specific clinical procedure it names. Issuers include city retirement offices (Phoenix), municipal health programs (Long Beach), state transportation agencies (Washington), county juvenile probation departments (Harris County, Texas), county human resources divisions (Collier County, Florida), and county health systems (Santa Clara County, California). Without evidence of actual intraluminal device or hepatobiliary procedure work in the recent solicitation stream, treating this code as a reliable signal for pursuing business in that specific clinical area would be misleading. Procurement professionals should verify scope alignment directly with issuing agencies before responding to opportunities tagged under this code.